EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pathogenesis of diffuse large B cell lymphoma proteogenotypes

Julius C Enssle, Björn Häupl, Arber Qoku, Boya Wang, George W Wright, Sharon Barrans, Yulai Zhou, Matthew A Care, Cathy Burton, Caitlin Gribbin, Jennifer Ziello, Jason Weirather und 32 weitere

Cancer Cell · 2026-07 · 44 (7) · 1437-1457.e14

DOI: 10.1016/j.ccell.2026.05.008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cell, 2026-07. Verfasst von Julius C Enssle und 43 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Hematology and Oncology, University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany; German Cancer Consorti…. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Leeds Biomedical Research Centre, European Research Council, Hessian Ministry of Science and Research Arts and Culture.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The clinical and molecular heterogeneity of diffuse large B cell lymphoma (DLBCL) is incompletely understood. By integrating proteomic, transcriptomic, and genomic data from 478 DLBCL tumors, we identify seven DLBCL proteogenotypes (PGs) reflecting specific pathophysiological features that span known molecular subtypes. PG4 is associated with poor outcome independent of established risk factors such as cell-of-origin, international prognostic index, or genetic features. PG4 contains activated B cell-like and germinal center B cell-like tumors and genetically unclassified cases. It shares a dark-zone-related B cell phenotype and shows enrichment for BTG1 mutations that can activate MYC. Single-cell sequencing and spatial transcriptomics reveal enhanced MYC and TCF3/4 transcriptional activity irrespective of MYC translocations. The PG4 tumor microenvironment is characterized by exhausted CD8+ T cells. Our study identifies common oncogenic themes underlying high-risk DLBCL tumors and provides a proteogenomic framework for future diagnostic and therapeutic approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Large B-Cell, DiffuseHumansTumor MicroenvironmentProto-Oncogene Proteins c-mycMutationProteomicsGene Expression Regulation, NeoplasticT-Cell ExhaustionPrognosisCD8-Positive T-LymphocytesProteogenomicsPhenotypeBasic Helix-Loop-Helix Proteins

Stichwörter der Autor:innen

B cell receptorMYCgenomicsimmune exhaustionlymphomamulti-omics data integrationprotein translationproteomicssingle cell sequencingtumor microenvironment

Substanzen

Proto-Oncogene Proteins c-mycTCF3 protein, humanMYC protein, humanBasic Helix-Loop-Helix Proteins

Autor:innen und Institutionen

  • Department of Medicine, Hematology and Oncology, University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, a Partnership Between DKFZ an…
  • German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, a Partnership Between DKFZ and UCT Frankfurt-Marburg, Germany, Frankfurt am Main, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany; Goethe…
  • Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Biometric Research Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Haematological Malignancy Diagnostic Service, St James' University Hospital, Leeds, UK.
  • Center of Molecular and Cellular Oncology, Yale Cancer Center, and Departments of Internal Medicine (Medical Oncology and Hematology) and Pathology, Yale School of Medicine, New Haven, CT, USA.

Förderung

  • Leeds Biomedical Research Centre
  • European Research Council
  • Hessian Ministry of Science and Research Arts and Culture
  • National Institutes of Health
  • Deutsche Forschungsgemeinschaft
  • German Cancer Aid
  • National Institute for Health and Care Research
  • Wellcome

Zitieren

APA

Enssle, J. C., Häupl, B., Qoku, A., Wang, B., Wright, G. W., Barrans, S., Zhou, Y., Care, M. A., Burton, C., Gribbin, C., Ziello, J., Weirather, J., Dai, Y., Kizhakeyil, A., Li, X., Phelan, J. D., Kanangat, S., Eckert, S., Scheich, S., …, & Oellerich, T. (2026). Pathogenesis of diffuse large B cell lymphoma proteogenotypes. Cancer Cell, 44(7), 1437-1457.e14. https://doi.org/10.1016/j.ccell.2026.05.008

Vancouver

Enssle JC, Häupl B, Qoku A, Wang B, Wright GW, Barrans S, et al. Pathogenesis of diffuse large B cell lymphoma proteogenotypes. Cancer Cell. 2026;44(7):1437-1457.e14. doi:10.1016/j.ccell.2026.05.008

BibTeX
@article{Enssle2026,
  author = {Enssle, Julius C and Häupl, Björn and Qoku, Arber and Wang, Boya and Wright, George W and Barrans, Sharon and Zhou, Yulai and Care, Matthew A and Burton, Cathy and Gribbin, Caitlin and Ziello, Jennifer and Weirather, Jason and Dai, Yibo and Kizhakeyil, Atish and Li, Xubin and Phelan, James D and Kanangat, Smriti and Eckert, Stephan and Scheich, Sebastian and Wolf, Sebastian and Huang, Da Wei and Jakob, Josefine and Perner, Sebastian P and Di Fonzo, Andrea and Pape, Martine and Bodach, Marion and Jahn, Dominique and Plessmann, Uwe and Staiger, Annette M and Ott, German and Berning, Philipp and Lenz, Georg and Hodson, Daniel J and Kuster, Bernhard and Schmitz, Roland and Urlaub, Henning and Green, Michael R and Melnick, Ari M and Tooze, Reuben and Mlynarczyk, Coraline and Inghirami, Giorgio and Buettner, Florian and Staudt, Louis M and Oellerich, Thomas},
  title = {Pathogenesis of diffuse large B cell lymphoma proteogenotypes},
  journal = {Cancer Cell},
  year = {2026},
  volume = {44},
  number = {7},
  pages = {1437--1457.e14},
  doi = {10.1016/j.ccell.2026.05.008}
}
Kostenlos starten →